21/03 | Blue shield of california - low-cost insulin one step closer with california-civica par.. |  |
21/03 | Fed Policy Meeting, Banks in Focus as Exchange-Traded Funds, Equity Futures Rise Premar.. |  |
21/03 | Sanofi, Regeneron Pharmaceuticals Say Dupixent Obtains European Approval to Treat Sever.. |  |
21/03 | Bolsa de Madrid: Cueste lo que cueste... |  |
21/03 | Sanofi, Regeneron's Dupixent Wins EU's First-in-Class Nod for Severe Atopic Dermatitis .. |  |
21/03 | Press Release : Dupixent® (dupilumab) approved by European Commission as first and only ta.. |  |
21/03 | Press Release : Dupixent® (dupilumab) approved by European Commission as first and only ta.. |  |
21/03 | European Commission Approves Dupixent of Regeneron Pharmaceuticals, Inc. and Sanofi |  |
20/03 | Vaccine makers prep bird flu shots for humans |  |
20/03 | Bolsa de Madrid: Otro banco que muerde el polvo |  |
20/03 | Vaccine makers prep bird flu shot for humans 'just in case'; rich nations lock in suppl.. |  |
18/03 | Press Release : Dupixent® (dupilumab) late-breaking data at AAD show significant improveme.. |  |
18/03 | Press Release : Dupixent® (dupilumab) late-breaking data at AAD show significant improveme.. |  |
17/03 | Healthcare Shares Decline With Focus on Drug Prices - Healthcare Roundup |  |
17/03 | Borse Europa in rialzo su minori turbolenze bancarie, bene energia |  |
17/03 | Bolsa de Madrid: ¿Fin de la Berezina? |  |
17/03 | MORNING BRIEFING - Deutschland/Europa -2- |  |
17/03 | MORNING BRIEFING - USA/Asien -2- |  |
17/03 | Marketmind: Support for troubled banks calms markets |  |
17/03 | France's Sanofi Joins Rivals in Slashing US Insulin Prices |  |
17/03 | Sanofi cuts insulin cost to $35, third major drug company to do so |  |
16/03 | Sanofi to cut US price of its most-prescribed insulin by 78% |  |
16/03 | Diabetes-Medikamentenriese Sanofi senkt Insulinpreise drastisch |  |
16/03 | Sanofi Cuts Lantus US List Price by 78%, Caps Insured Out-of-Pocket Cost to $35 |  |
16/03 | Sanofi to cut price of its most-prescribed insulin by 78% in US |  |
16/03 | Sanofi Cuts US Price of Lantus Insulin by 78% |  |
16/03 | Sanofi Cuts US Price of Lantus Insulin by 78% |  |
16/03 | Press Release : Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78.. |  |
16/03 | Press Release : Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78.. |  |
14/03 | Sanofi Announces Acceptance of Dupixent Application for Treatment of Chronic Spontaneou.. |  |
14/03 | Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifyi.. |  |
14/03 | Novo Nordisk senkt Insulinpreise ab 2024 um bis zu 75 Prozent |  |
14/03 | Novo Nordisk planea reducir hasta un 75% el precio de la insulina en EEUU |  |
13/03 | Healthcare Shares Climb Amid Deal News -- Healthcare Roundup |  |
13/03 | Aktien New York Schluss: Stabilisierung - Übernahmen stützen Nas.. |  |
13/03 | MÄRKTE USA/Wall Street uneinheitlich - Bankenwerte stürzen ab |  |
13/03 | Bankendrama zet Wall Street onder druk |  |
13/03 | Sector Update: Health Care Stocks Close with Solid Monday Gains |  |
13/03 | Sector Update: Health Care Maintaining Monday Rebound |  |
13/03 | Aktien New York: Stabilisierung trotz Bankenkrise - Übernahmen beflügen .. |  |
13/03 | Top Midday Gainers |  |
13/03 | Sector Update: Health Care |  |
13/03 | Handel Wall Street volatiel |  |
13/03 | LATE BRIEFING - Unternehmen und Märkte |  |
13/03 | MÄRKTE EUROPA/Ausverkauf nach SVB-Schieflage - Banken brechen ein |  |
13/03 | Dpa-AFX-Überblick: UNTERNEHMEN vom 13.03.2023 - 15.15 Uhr |  |
13/03 | MÄRKTE EUROPA/DAX kämpft mit 15.000er-Marke - Lufthansa leiden unter Streiks |  |
13/03 | Sector Update: Health Care Stocks Advance in Early Monday Morning Trade |  |
13/03 | Sector Update: Health Care |  |
13/03 | Traders Assess US Moves to Contain Bank Fallout, Prompting Lower Premarket Session for .. |  |
13/03 | Futures Wall Street verdeeld |  |
13/03 | ANALYSE/Regeneron hält Big Pharma mit deren Waffen in Schach |  |
13/03 | Fed's US Bank Rescue Lifts Exchange-Traded Funds, Equity Futures Pre-Bell Monday |  |
13/03 | MIDDAY BRIEFING - Unternehmen und Märkte -2- |  |
13/03 | Top Premarket Gainers |  |
13/03 | French Bourse Kicks Off Week Deep in Red after Silicon Valley Bank Collapse |  |
13/03 | Sanofi to Acquire Provention Bio in $2.9 Billion Deal |  |
13/03 | European Midday Briefing: Investors Weigh SVB Contagion Risk |  |
13/03 | North American Morning Briefing: Investors Digest Emerge.. |  |
13/03 | Sanofi to Boost General Medicines Portfolio Via $3 Billion Takeover of US-based Provent.. |  |
13/03 | La francesa Sanofi compra la estadounidense Provention Bio por 2.900 millones de dólare.. |  |
13/03 | Sanofi stärkt Diabetes-Geschäft mit Milliardenzukauf |  |
13/03 | Bolsa de Madrid: El Equipo A |  |
13/03 | Sanofi will Provention Bio kaufen |  |
13/03 | Sanofi kauft Provention Bio für rund 2,9 Mrd USD |  |
13/03 | Live Stock Market Blog - March 13, 2023 - Business AM |  |
13/03 | MORNING BRIEFING - Deutschland/Europa -2- |  |
13/03 | Sanofi to Acquire Provention Bio for Around $2.9 Billion |  |
13/03 | France's Sanofi to acquire US-based Provention Bio for $2.9 billion |  |
13/03 | Sanofi to Buy Autoimmune Disease-focused Provention Bio for $2.9 Billion |  |
13/03 | Sanofi neemt Provention Bio over in miljardendeal |  |
13/03 | Galderma posts 2022 revenue growth ahead of planned IPO |  |
13/03 | Press Release : Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first di.. |  |
13/03 | Sanofi (ENXTPA:SAN) entered into an agreement to acquire 97.023% stake in.. |  |
09/03 | US Lawmakers Introduce Bill Capping Insulin Price at $20 Per Vial |  |
09/03 | Sanofi : Rapport Financiére |  |
08/03 | Bolsa de Madrid: Don't fight the Fed, o de manera discreta |  |
07/03 | Sanofi, Regeneron Say US FDA Accepted Supplemental Biologics License Application for Du.. |  |
07/03 | European Midday Briefing: Powell Testimony in Focus |  |
07/03 | Bolsa de Madrid: Ha vuelto, pero ¿está contento? |  |
07/03 | Sanofi, Regeneron Seek US FDA Nod for Dupixent's Use in Treating Hives |  |
07/03 | Press Release : Dupixent® (dupilumab) application for treatment of chronic spontaneous urt.. |  |
07/03 | Regeneron Pharmaceuticals, Inc. and Sanofi Announce U.S. Food and Drug Administration A.. |  |
07/03 | Regeneron Pharmaceuticals, Inc. and Sanofi Announce U.S. Food and Drug Administration A.. |  |
07/03 | Sanofi Announces U.S. Food and Drug Administration Has Accepted, for Review, the Supple.. |  |
07/03 | Press Release : Dupixent® (dupilumab) application for treatment of chronic spontaneous urt.. |  |
06/03 | Sanofi inaugura su nueva sede central en España con 800 trabajadores |  |
06/03 | Merck's drug boosts exercise capacity in pulmonary hypertension patients |  |
06/03 | Merck's drug boosts exercise capacity in pulmonary hypertension patients |  |
06/03 | Stada profitiert von Krankheitswelle und starkem Russland-Geschäft |  |
02/03 | Correction: Sanofi, Sobi's Rare Bleeding Disorder Drug Shown Safe for Kids in.. |  |
02/03 | Successful Transaction : Adragos Pharma has officially taken over the Sanofi production si.. |  |
02/03 | Sanofi, Sobi's Rare Bleeding Disorder Drug Shown Safe for Kids in Late-stage Study |  |
02/03 | Positive topline results from pivotal XTEND-Kids phase 3 study of efanesoctocog alfa in.. |  |
02/03 | Press Release : Completed XTEND-Kids Phase 3 study strengthens potential of ALTUVIIIOTM to.. |  |
02/03 | Sobi and Sanofi Announces Positive Topline Results from Pivotal XTEND- Kids Phase 3 Stu.. |  |
02/03 | Press Release : Completed XTEND-Kids Phase 3 study strengthens potential of ALTUVIIIOTM to.. |  |
02/03 | Merck KGaA expects 2023 profit to slip as COVID demand wanes |  |
01/03 | Lilly reducirá un 70% el precio de la insulina en EEUU a partir del cuarto trimestre |  |
01/03 | Eli Lilly to Cut Some Insulin Prices by 70% |  |